Market Research

Colorado’s progressive step toward legalizing psilocybin, primarily for therapeutic purposes, has opened new doors for individuals seeking alternative mental health treatments. As of 2023, residents can apply for access to licensed psilocybin therapy sessions under regulated conditions, providing a safe environment for therapeutic and controlled use. This landmark move is a part of Proposition 122,…

Compass Pathways (NASDAQ: CMPS) has announced plans to reduce its workforce by approximately 30% and halt early-stage research programs, as the company intensifies its focus on the late-stage development of its lead candidate, the COMP360 psilocybin therapy. The London-based mental health company revealed its restructuring strategy alongside its third-quarter financial results, which highlighted an increased…

The journey toward FDA approval for new drugs is fraught with challenges, but perhaps none is more critical than the proper structuring of clinical trials. This point was starkly illustrated by the recent decision of the U.S. Food and Drug Administration (FDA) to decline the approval of an MDMA-based treatment for post-traumatic stress disorder (PTSD)…

The journey to healing from depression often demands more than just symptom management; it requires a deep, inner transformation that addresses the root of emotional distress. This inner healing process is crucial for those suffering from depression, as it can lead to more profound and lasting recovery. Emerging research on psychedelics, particularly psilocybin, is shedding…